PubMed:1939341 / 1580-1778 JSONTXT

{"project":"jnlpba-st-training","denotations":[{"id":"T20","span":{"begin":13,"end":16},"obj":"protein"},{"id":"T21","span":{"begin":77,"end":100},"obj":"cell_line"},{"id":"T22","span":{"begin":153,"end":161},"obj":"DNA"},{"id":"T23","span":{"begin":180,"end":197},"obj":"DNA"}],"text":"Increases in CAT activity during transient expression of these constructs in TPA-treated U-937 cells could be assigned to the region (-97 to -20) of the promoter that contains the AP-1 binding site."}

{"project":"semrep-sample","denotations":[{"id":"E1-ab-8","span":{"begin":0,"end":9},"obj":"cui:C0442805"},{"id":"E2-ab-8","span":{"begin":13,"end":16},"obj":"cui:C0008168"},{"id":"E3-ab-8","span":{"begin":13,"end":25},"obj":"cui:C1151922"},{"id":"E4-ab-8","span":{"begin":33,"end":42},"obj":"cui:C0205374"},{"id":"E5-ab-8","span":{"begin":43,"end":53},"obj":"cui:C0185117"},{"id":"E6-ab-8","span":{"begin":77,"end":80},"obj":"cui:C0039654"},{"id":"E7-ab-8","span":{"begin":81,"end":88},"obj":"cui:C1292734"},{"id":"E8-ab-8","span":{"begin":89,"end":100},"obj":"cui:C0301863"},{"id":"E9-ab-8","span":{"begin":126,"end":132},"obj":"cui:C0205147"},{"id":"E10-ab-8","span":{"begin":180,"end":184},"obj":"cui:C0002059"},{"id":"E11-ab-8","span":{"begin":185,"end":197},"obj":"cui:C0005456"},{"id":"T18","span":{"begin":0,"end":9},"obj":"AUGMENTS"}],"relations":[{"id":"R35","pred":"subjectOf","subj":"E11-ab-8","obj":"T18"},{"id":"R36","pred":"objectOf","subj":"E3-ab-8","obj":"T18"}],"text":"Increases in CAT activity during transient expression of these constructs in TPA-treated U-937 cells could be assigned to the region (-97 to -20) of the promoter that contains the AP-1 binding site."}

{"project":"pubmed-sentences-benchmark","denotations":[{"id":"S9","span":{"begin":0,"end":198},"obj":"Sentence"}],"text":"Increases in CAT activity during transient expression of these constructs in TPA-treated U-937 cells could be assigned to the region (-97 to -20) of the promoter that contains the AP-1 binding site."}

{"project":"genia-medco-coref","denotations":[{"id":"C36","span":{"begin":13,"end":16},"obj":"NP"},{"id":"C35","span":{"begin":13,"end":25},"obj":"NP"},{"id":"C37","span":{"begin":77,"end":100},"obj":"NP"},{"id":"C38","span":{"begin":149,"end":161},"obj":"NP"},{"id":"C39","span":{"begin":162,"end":166},"obj":"NP"},{"id":"C40","span":{"begin":176,"end":197},"obj":"NP"}],"relations":[{"id":"R27","pred":"coref-relat","subj":"C39","obj":"C38"}],"text":"Increases in CAT activity during transient expression of these constructs in TPA-treated U-937 cells could be assigned to the region (-97 to -20) of the promoter that contains the AP-1 binding site."}

{"project":"GENIAcorpus","denotations":[{"id":"T41","span":{"begin":13,"end":16},"obj":"protein_molecule"},{"id":"T42","span":{"begin":33,"end":53},"obj":"other_name"},{"id":"T43","span":{"begin":77,"end":80},"obj":"other_organic_compound"},{"id":"T44","span":{"begin":153,"end":161},"obj":"DNA_domain_or_region"},{"id":"T45","span":{"begin":180,"end":197},"obj":"DNA_domain_or_region"}],"text":"Increases in CAT activity during transient expression of these constructs in TPA-treated U-937 cells could be assigned to the region (-97 to -20) of the promoter that contains the AP-1 binding site."}

{"project":"metamap-sample","denotations":[{"id":"T15","span":{"begin":181,"end":185},"obj":"C0085828"},{"id":"T23","span":{"begin":78,"end":81},"obj":"C0039654"},{"id":"T64","span":{"begin":44,"end":54},"obj":"C0185117"},{"id":"T70","span":{"begin":186,"end":198},"obj":"C0005456"},{"id":"T76","span":{"begin":1,"end":10},"obj":"C0442805"},{"id":"T87","span":{"begin":154,"end":162},"obj":"C0086860"},{"id":"T91","span":{"begin":82,"end":89},"obj":"C1522326"},{"id":"T94","span":{"begin":14,"end":26},"obj":"C1151952"},{"id":"T101","span":{"begin":168,"end":176},"obj":"C2700400"},{"id":"T108","span":{"begin":64,"end":73},"obj":"C2827421"},{"id":"T116","span":{"begin":136,"end":138},"obj":"C0439082"},{"id":"T124","span":{"begin":111,"end":119},"obj":"C1552601"},{"id":"T125","span":{"begin":127,"end":133},"obj":"C0205147"},{"id":"T132","span":{"begin":34,"end":43},"obj":"C0205374"}],"text":"Increases in CAT activity during transient expression of these constructs in TPA-treated U-937 cells could be assigned to the region (-97 to -20) of the promoter that contains the AP-1 binding site."}